— Know what they know.
Not Investment Advice
Asset Manager ← All Institutions

Pfizer Inc

Q1 2026 · Filed 2026-05-12
Market Value
$218M
+1.2%
Holdings
16
-2
New Purchases
1
Added To
0
Closed
1
Reduced
4
Top 10 Concentration
98.5%
Turnover
12.5%

Top Buys (by % of Portfolio)

SymbolCur %Prior %Chg %Value
ALLO 22.87% 14.03% +8.85% $50M
ORIC 26.48% 20.44% +6.04% $58M
PYXS 4.23% 3.76% +0.47% $9M
AGMB 0.37% 0.00% +0.37% $814K
CRBU 3.84% 3.47% +0.37% $8M
ZNTL 0.92% 0.60% +0.32% $2M

Top Sells (by % of Portfolio)

SymbolCur %Prior %Chg %Value
WVE 5.48% 14.81% -9.33% $12M
ARVN 16.04% 19.06% -3.02% $35M
CELC 14.40% 16.20% -1.80% $31M
CRDF 1.72% 3.15% -1.43% $4M
ANTX 0.00% 0.38% -0.38% $0
NXTC 0.71% 1.04% -0.33% $2M
QTTB 0.34% 0.43% -0.09% $737K
SPRO 2.53% 2.56% -0.03% $6M
BOLT 0.06% 0.08% -0.02% $137K
DNA 0.01% 0.01% -0.00% $17K

Sector Allocation Over Time

Market Cap Concentration

TierHoldingsValueWeight
Mid Cap 1 $31M 14.4%
Small Cap 6 $155M 71.3%
Micro Cap 9 $31M 14.3%

Portfolio Analytics

Avg Market Cap
$760M
Median Market Cap
$249M
Avg P/E
6.4
Median P/E
6.4
Avg Dividend Yield
—%
Avg Beta
0.79
# Stocks
16
# ETFs / Funds
0

Top Holdings (16 total)

# Symbol % Port Shares Value Avg Price Q/Q Value Chg Share Chg Chg % Status
1 ORIC 26.48% 4,780,401 $58M $12.06 $14M -595,943 -11.1%
2 ALLO 22.87% 22,032,040 $50M $2.26 $20M
3 ARVN 16.04% 3,457,815 $35M $10.10 -$6M
4 CELC 14.40% 295,652 $31M $106.02 -$4M -53,754 -15.4%
5 WVE 5.48% 1,875,000 $12M $6.37 -$20M
6 PYXS 4.23% 7,032,770 $9M $1.31 $1M
7 CRBU 3.84% 4,690,431 $8M $1.78 $891K
8 SPRO 2.53% 2,362,348 $6M $2.33
9 CRDF 1.72% 2,411,575 $4M $1.55 -$3M
10 ZNTL 0.92% 953,834 $2M $2.10 $715K
11 NXTC 0.71% 153,354 $2M $10.01 -$702K -4,292 -2.7%
12 AGMB 0.37% 75,000 $814K $10.85 +75,000 NEW
13 QTTB 0.34% 101,618 $737K $7.25 -$185K -176,159 -63.4%
14 BOLT 0.06% 31,305 $137K $4.38 -$34K
15 DNA 0.01% 2,928 $17K $5.93 -$7K
16 ANTX —% -$815K -715,295 -100.0% SOLD

New Positions

SymbolValue% Port
AGMB $814K 0.37%

Sold Out Positions

SymbolValue% Port
ANTX —%
View SEC EDGAR Filings for Pfizer Inc →

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms